Hochschulschrift

Untersuchung von altersabhängigen Veränderungen der paraspinalen Muskulatur mit monoklonalen Antikörpern gegen Myosin-heavy-chain Muskelfaserstrukturproteine mittels Immunfluoreszenz

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Deutsch

Notes: Universität Freiburg, Dissertation, 2014

Keyword: Muskelfaser
Monoklonaler Antikörper
Immunfluoreszenz
Myosin
Muskulatur
Enzym
Oberschenkel
Kollagen
Skelettmuskel
Myosin
Muskulatur
Immunfluoreszenz
Antikörper
Rückenmuskulatur
Kamptokormie
Muskelkrankheit
Online-Ressource
Immunologie
Immunsystem
Lymphozyt
Leukozyt
Immunität
Resistenz
Immunchemie

Event: Veröffentlichung

(where): Freiburg

(who): Universität

(when): 2014

Creator: Nagelmann, Alexander

Contributor: Kirschner, Janbernd

URN: urn:nbn:de:bsz:25-opus-96759

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Object type

Hochschulschrift

Associated

Time of origin

2014

Other Objects (12)

Nusinersen - praktische Aspekte der Therapie bei Spinaler Muskelatrophie im klinischen Allltag

Hochschulschrift

Die Hospizbewegung in Deutschland am Beispiel Recklinghausen

Diagnostik und Therapie der Spinalen Muskelatrophie

Correction to: Risdiplam inpatients previously treated with other therapies for spinal muscular atrophy: an interim analysis from the JEWELFISH study

Advances in treatment of spinal muscular atrophy – new phenotypes, new challenges, new implications for care

Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study

A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial

The TREAT‐NMD DMD global database: analysis of more than 7,000 duchenne muscular dystrophy mutations

Clinical outcomes in Duchenne Muscular Dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database

Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of the NURTURE study

Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study

Nusinersen - praktische Aspekte der Therapie bei Spinaler Muskelatrophie im klinischen Allltag

Hochschulschrift

Die Hospizbewegung in Deutschland am Beispiel Recklinghausen

Diagnostik und Therapie der Spinalen Muskelatrophie

Correction to: Risdiplam inpatients previously treated with other therapies for spinal muscular atrophy: an interim analysis from the JEWELFISH study

Advances in treatment of spinal muscular atrophy – new phenotypes, new challenges, new implications for care

Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study

A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial

The TREAT‐NMD DMD global database: analysis of more than 7,000 duchenne muscular dystrophy mutations

Clinical outcomes in Duchenne Muscular Dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database

Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of the NURTURE study

Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study

Nusinersen - praktische Aspekte der Therapie bei Spinaler Muskelatrophie im klinischen Allltag

Hochschulschrift

Die Hospizbewegung in Deutschland am Beispiel Recklinghausen

Diagnostik und Therapie der Spinalen Muskelatrophie

Correction to: Risdiplam inpatients previously treated with other therapies for spinal muscular atrophy: an interim analysis from the JEWELFISH study

Advances in treatment of spinal muscular atrophy – new phenotypes, new challenges, new implications for care

Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study

A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial

The TREAT‐NMD DMD global database: analysis of more than 7,000 duchenne muscular dystrophy mutations

Clinical outcomes in Duchenne Muscular Dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database

Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of the NURTURE study

Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Untersuchung von altersabhängigen Veränderungen der paraspinalen Muskulatur mit monoklonalen Antikörpern gegen Myosin-heavy-chain Muskelfaserstrukturproteine mittels Immunfluoreszenz

Object Details

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Object type

Associated

Time of origin

Other Objects (12)

Nusinersen - praktische Aspekte der Therapie bei Spinaler Muskelatrophie im klinischen Allltag

Die Hospizbewegung in Deutschland am Beispiel Recklinghausen

Diagnostik und Therapie der Spinalen Muskelatrophie

Correction to: Risdiplam inpatients previously treated with other therapies for spinal muscular atrophy: an interim analysis from the JEWELFISH study

Advances in treatment of spinal muscular atrophy – new phenotypes, new challenges, new implications for care

Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study

A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial

The TREAT‐NMD DMD global database: analysis of more than 7,000 duchenne muscular dystrophy mutations

Clinical outcomes in Duchenne Muscular Dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database

Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of the NURTURE study

Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study

Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study

Nusinersen - praktische Aspekte der Therapie bei Spinaler Muskelatrophie im klinischen Allltag

Die Hospizbewegung in Deutschland am Beispiel Recklinghausen

Diagnostik und Therapie der Spinalen Muskelatrophie

Correction to: Risdiplam inpatients previously treated with other therapies for spinal muscular atrophy: an interim analysis from the JEWELFISH study

Advances in treatment of spinal muscular atrophy – new phenotypes, new challenges, new implications for care

Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study

A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial

The TREAT‐NMD DMD global database: analysis of more than 7,000 duchenne muscular dystrophy mutations

Clinical outcomes in Duchenne Muscular Dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database

Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of the NURTURE study

Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study

Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study

Nusinersen - praktische Aspekte der Therapie bei Spinaler Muskelatrophie im klinischen Allltag

Die Hospizbewegung in Deutschland am Beispiel Recklinghausen

Diagnostik und Therapie der Spinalen Muskelatrophie

Correction to: Risdiplam inpatients previously treated with other therapies for spinal muscular atrophy: an interim analysis from the JEWELFISH study

Advances in treatment of spinal muscular atrophy – new phenotypes, new challenges, new implications for care

Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study

A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial

The TREAT‐NMD DMD global database: analysis of more than 7,000 duchenne muscular dystrophy mutations

Clinical outcomes in Duchenne Muscular Dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database

Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of the NURTURE study

Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study

Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study

Related objects

Reset password